胃肠道出血中的静脉西胺酸:随机对照试验的系统综述和元分析
Tarek Djoudjou1, Osama Alamri2, Abdulrahman Aljuwayr3
1Dr. Sulaiman Alhabib Medical group, Riyadh, Saudi Arabia.
The American journal of emergency medicine
|August 2, 2025
概括
特兰胺酸 (TXA) 有效地降低了胃肠道出血中的再出血和出血控制失败. 然而,TXA不会显著影响死亡率,并带有潜在的血栓栓塞风险,需要仔细考虑.
科学领域:
- 胃肠病学 胃肠病学
- 血液学 血液学 血液学
- 关键护理医学 关键护理医学
背景情况:
- 胃肠道出血具有显著的发病率和死亡率.
- 目前正在研究一种抗纤维素解药物特兰胺酸 (TXA),用于控制出血.
- 最近试验的相互矛盾结果需要进一步调查TXA的作用.
研究的目的:
- 系统地审查和对静脉注射TXA用于胃肠道出血的随机对照试验 (RCT) 进行元分析.
- 评估TXA在减少死亡率,再出血和输血需求方面的有效性和安全性.
- 为了评估与TXA使用相关的血栓栓塞事件的风险.
主要方法:
- 遵守PRISMA系统审查和元分析指南.
- 在PubMed和谷歌学者的搜索中,从518个出版物中确定了7个相关的RCT.
- 随机效应模型用于数据合成,评估关键临床结果.
主要成果:
- IV TXA显著降低了复出出血率 (OR 0.64) 和无法控制出血 (OR 0.55).
- 没有观察到死亡率 (OR 0.77) 或输血需求 (OR 0.94) 的显著降低.
- 血栓塞栓事件在随机效应分析中没有显著差异,但固定效应分析表明意义.
结论:
- 静脉注射TXA有效地降低了胃肠道出血中的再出血和出血控制失败.
- TXA并没有显著降低死亡率.
- 由于潜在的血栓栓塞风险,建议谨慎使用;为了优化TXA使用,需要进一步研究.
相关概念视频
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Esophageal Varices-II: Clinical Features and Management
140
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
140
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
909
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
909
Venous Thrombosis IV: Nursing Management
23
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
23
Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57


